Using a newly developed nano-size biosensor, UT scientists Pepijn Beekman and Dilu Mathew can detect small tumor cell fragments in blood at very low concentrations. These so-called tumor-derived extracellular vesicles (tdEVs) are effective biomarkers for the presence and activity of a tumor.
Cancer is the second main cause of death in the world. This is partly due to issues in cancer treatment, specifically the late detection of the disease. It is therefore paramount to develop novel detection methods and PhD researcher Agustin Enciso-Martinez is working on precisely that.
His aspiration was to save lives, and so he decided to switch from engineering to nanotechnology. The place to do that was the UT, where Dilu George Mathew now works on ‘Early Stage Cancer Detection Sensor’, a device able to detect cancer from patients’ urine. ‘This technique could not only save lives, but also a lot of money.’